Nitrase Therapeutics, Inc.

Nitrase Therapeutics is building a platform around a newly identified class of enzymes to target Parkinsonโ€™s disease, dementia with Lewy bodies, and other age-related disorders.

All Portfolio Companies
Location
US
Fund
DDF-1